# Comparison of Biomatrix and Orsiro Drug Eluting Stent

Study · id `cardio:ct-nct02299011` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02299011](<https://clinicaltrials.gov/study/NCT02299011>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02299011

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2341 participants.

## Technical summary

Registry record NCT02299011. Randomized; no masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2019-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2341 participants (enrolled count; ClinicalTrials.gov record NCT02299011, source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)
- Started: 2014-07 (actual) (ClinicalTrials.gov record NCT02299011, source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)
- Primary completion: 2019-06 (actual) (ClinicalTrials.gov record NCT02299011, source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)
- Completion: 2019-09 (actual) (ClinicalTrials.gov record NCT02299011, source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02299011, source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02299011-2019-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Biomatrix and Orsiro Drug Eluting Stent
- Acronym: BIODEGRADE
- Condition: Coronary Artery Disease
- Condition: Myocardial Ischemia
- Intervention (Device): Orsiro drug eluting stent
- Intervention (Drug): Biomatrix drug eluting stent
- Lead sponsor: Seoul National University Bundang Hospital
- Lead sponsor class: OTHER
- Collaborator: Wonju Severance Christian Hospital
- Collaborator class: OTHER
- Collaborator: Korea University Guro Hospital
- Collaborator class: OTHER
- Collaborator: Gangnam Severance Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER
- Collaborator: The Catholic University of Korea
- Collaborator class: OTHER
- Collaborator: Korea University Anam Hospital
- Collaborator class: OTHER
- Collaborator: Kosin University Gospel Hospital
- Collaborator class: OTHER
- Collaborator: KangWon National University Hospital
- Collaborator class: OTHER
- Collaborator: Gachon University Gil Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)
- Registry lists this organization as a collaborator: Wonju Severance Christian Hospital (`cardio:org-wonju-severance-christian-hospital`)
- Registry lists this organization as a collaborator: Korea University Guro Hospital (`cardio:org-korea-university-guro-hospital`)
- Registry lists this organization as a collaborator: Gangnam Severance Hospital (`cardio:org-gangnam-severance-hospital`)
- Registry lists this organization as a collaborator: Chungnam National University Hospital (`cardio:org-chungnam-national-university-hospital`)
- Registry lists this organization as a collaborator: The Catholic University of Korea (`cardio:org-the-catholic-university-of-korea`)
- Registry lists this organization as a collaborator: Korea University Anam Hospital (`cardio:org-korea-university-anam-hospital`)
- Registry lists this organization as a collaborator: Kosin University Gospel Hospital (`cardio:org-kosin-university-gospel-hospital`)
- Registry lists this organization as a collaborator: KangWon National University Hospital (`cardio:org-kangwon-national-university-hospital`)
- Registry lists this organization as a collaborator: Gachon University Gil Medical Center (`cardio:org-gachon-university-gil-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study (`cardio:pubmed-36475473`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8c5a7001f40c659114fa44df2e947cd8642b477ecc933708db16d57b14d6e321
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
